Advances in Urothelial Carcinoma: Expert Insights to Guide Clinical Practice

Gain interdisciplinary perspectives on optimal management of patients with advanced urothelial carcinoma with these downloadable slides, expert commentary, and short virtual presentations, as well as an updated decision support tool.
Matthew Galsky, MD

ClinicalThought

In this commentary, bladder cancer expert Matthew Galsky, MD, answers questions on the use of immune checkpoint blockade in first-line treatment, switch maintenance, and adjuvant therapy.

Matthew Galsky, MD Released: November 19, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue